Anti-tumour necrosis factor-α therapy for severe enteropathy in patients with common variable immunodeficiency (CVID)

We present three common variable immunodeficiency (CVID) patients with severe inflammatory bowel disease of unknown aetiology, resistant to steroid treatment, treated with infliximab. After exclusion of any infection, infliximab was given at a dose of 5 mg/kg every 4 weeks for a 3 month induction fo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chua, I, Standish, R, Lear, S, Harbord, M, Eren, E, Raeiszadeh, M, Workman, S, Webster, D
Format: Article
Idioma:English
Publicat: Blackwell Publishing Ltd 2007
Matèries:
Translational Studies
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2219360/
https://ncbi.nlm.nih.gov/pubmed/17822445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2007.03481.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC2219360/
https://ncbi.nlm.nih.gov/pubmed/17822445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2007.03481.x

Ítems similars